Target intelligence / Profile preview

Spleen Tyrosine Kinase (SYK)

Target
SYK
Molecular classification
Enzyme, Protein Kinase, Tyrosine Kinase, Non-receptor tyrosine kinase
01

Overview

Spleen tyrosine kinase (SYK) is a cytoplasmic, non-receptor protein tyrosine kinase crucial for transducing signals from immune cell receptors, regulating cellular responses to antigens and immune complexes. It is primarily expressed in hematopoietic cells. SYK activation involves SH2 domain binding to phosphorylated ITAMs and subsequent autophosphorylation, leading to activation of downstream signaling pathways such as PI3K/Akt, Ras/ERK, PLCγ/NFAT, Vav/Rac, and IKK/NFκB. It plays critical roles in autoimmune diseases and cancer, making it a relevant therapeutic target. However, safety concerns exist regarding immunosuppression and off-target effects. SYK can also act as a tumor suppressor or promoter depending on the context.

02

Mechanism of action

Small-molecule inhibitors targeting the ATP-binding site or SH2 domains, preventing ITAM binding and downstream signaling

03

Biological functions

Immune receptor signalingSignal transductionCell adhesionOsteoclast maturationPlatelet activationVascular developmentAlpha-tubulin kinaseRegulation of inflammatory pathways
04

Disease associations

AutoimmunityInflammationCancerCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Potential for immunosuppressionOff-target effects due to kinase promiscuityContext-dependent tumor suppressor or promoter activity
06

Interacting drugs

Fostamatinib

Beyond the preview

Go deeper on Spleen Tyrosine Kinase (SYK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spleen Tyrosine Kinase (SYK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call